Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation
Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation
复制标题
Iptakalim 可防止 MPP 诱导的与星形胶质细胞激活相关的多巴胺能神经元变性。
DOI:
10.1017/s1461145708009243
复制
发表时间:
2009-04-01
影响因子:
4.8
通讯作者:
Hu, Gang
中科院分区:
文献类型:
--
作者:
Yang, Yan-Jing;Zhang, Shu;Hu, Gang
Astrocyte activation observed in the MPTP mouse model and Parkinson's disease patients participates in the cascade of deleterious events that ultimately leads to death of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The present study aimed to elucidate whether inhibiting astrocyte activation was involved in the protective effects of iptakalim (Ipt), a novel ATP-sensitive potassium channel opener, on MPP+-induced degeneration of dopaminergic neurons. The results showed that Ipt could decrease MPP+-induced TNF-alpha release and p38 MAPK activation in reactive astrocytes. The effects of Ipt were reversed by the mitochondrial KATP blocker, 5-hydroxydecanoate, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation. Moreover, systematic administration of Ipt could significantly alleviate MPP+-induced behavioural symptoms in motor coordination, the loss of dopaminergic neurons, and the activation of astrocyte and microglia in the SNpc. Together, these findings suggest that Ipt may protect against MPP+-induced degeneration of dopaminergic neurons by inhibiting astrocyte activation and subsequent release of pro-inflammatory factors.